The Prognosis of Liver Cirrhosis in Recent Years in Korea

Journal of Korean Medical Science

Volumn 18, Issue 6, 2003, Pages 833-841

  Kim, Young Sun ^a   Um, Soon Ho ^a   Ryu, Ho Sang ^a   Lee, Jung Bok ^b   Lee, Jae Won ^b   Park, Dong Kyu ^a   Kim, Yong Sik ^a   Jin, Yoon Tae ^a   Chun, Hoon Jai ^a   Lee, Hong Sik ^a   Lee, Sang Woo ^a   Choi, Jai Hyun ^a   Kim, Chang Duck ^a   Hyun, Jin Hai ^a  

^a Korea University College of Medicine   (South Korea)

^b Korea University   (South Korea)

Author keywords

Alcoholic; Carcinoma; Esophageal and Gastric Varices; Hemorrhage; Hepatocellular; Liver Cirrhosis; Prognosis; Survival Analysis; Survival Rate

Indexed keywords

ALCOHOL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BACTERIAL PERITONITIS; CANCER DIAGNOSIS; CLINICAL FEATURE; CLINICAL OBSERVATION; CONTROLLED STUDY; DEATH; DISEASE COURSE; EARLY DIAGNOSIS; ECHOGRAPHY; ENDOSCOPY; FEMALE; FOLLOW UP; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; INCIDENCE; KOREA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; PROPHYLAXIS; SCORING SYSTEM; SURVIVAL;

EID: 0347694799     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2003.18.6.833     Document Type: Article

References (29)

1. Korean National Statistical Office. Annual Report on the Causes of Death Statistics. Seoul 1999: 25-7 (in Korean).
2. Lee DH, Kim JH, Nam JJ, Kim HR, Shin HR. Epidemiological findings of hepatitis B infection based on 1998 National Health and Nutrition Survey in Korea. J Korean Med Sci 2002; 17: 457-62.
3. Saunders JB, Walters JRF, Davies AP, Paton A. A 20-year prospective study of cirrhosis. Br Med J 1981; 282: 263-6.
4. D'Amico G, Morabito A, Pagliaro L, Marubini E, the liver study group of "V. Cervello" Hospital. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 1986; 31: 468-75.
5. Ginés P, Quintero E, Arroyo V, Terés J, Bruguera M, Rimola A, Caballería J, Rodés J, Rozman C. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987; 7: 122-8.
6. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995; 22: 332-54.
7. Farinati F, Gianni S, Marin G, Fagiuoli S, Rinaldi M, Naccarato R. Does the choice of treatment influence survival of patients with small hepatocellular carcinoma in compensated cirrhosis? Eur J Gastroenterol Hepatol 2001; 13: 1217-24.
8. Scheuer PJ. Liver biopsy in the diagnosis of cirrhosis. Gut 1970; 11: 275-8.
9. Runyon BA. Spontaneous bacterial peritonitis: An explosion of information. Hepatology 1988; 8: 171-5.
10. Sherlock S, Dooley J. Disease of the liver and biliary system, 11th ed. Oxford: Blackwell Science, 2002: 93-109.
11. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-9.
12. Beppu K, Inokuchi K, Koyanagi N, Nakayama S, Sakata H, Kitano S, Kobayashi M. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 1981; 27: 213-8.
13. de Franchis R. Updating consensus in portal hypertension: report of Baveno III consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000; 33: 846-52.
14. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999; 19: 329-38.
15. Kaplan GL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958; 53: 457-81.
16. Cox DR. Regression models and life tables. J R Stat Soc B 1972; 34: 187-220.
17. Christensen E. Prognostic models in chronic liver disease: validity, usefulness and future role. J Hepatol 1997; 26: 1414-24.
18. Christensen E, Schlichting P, Andersen PK, Fauerholdt L, Schou G, Pedersen BV, Juhl E, Poulsen H, Tygstrup, N Copenhagen study group for liver disease. Updating prognosis and therapeutic effect evaluation in cirrhosis with Cox's multiple regression model for time-dependent variables. Scand J Gastroenterol 1986; 21: 163-74.
19. de Jongh FE, Janssen HL, de Man RA, Hop WC, Schalm SW, van Blankenstein M. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. Gastroenterology 1992; 103: 1630-5.
20. Powell WJ Jr, Klatskin G. Duration of survival in patients with Laennec's cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease. Am J Med 1968; 44: 406-20.
21. Burroughs AK, D'heygere F, McIntyre N. Pitfalls in studies of prophylactic therapy for variceal bleeding in cirrhotics. Hepatology 1986; 6: 1407-13.
22. Hoefs JC, Canawati HN, Sapico FL, Hopkins RR, Weiner J, Montgomerie JZ. Spontaneous bacterial peritonitis. Hepatology 1982; 2: 399-407.
23. Runyon BA, Hoefs JC. Culture-negative neutrocytic ascites: a variant of spontaneous bacterial peritonitis. Hepatology 1984; 4: 1209-11.
24. Tito L, Rimola A, Ginés P, Llach J, Arryo V, Rodés J. Recurrence of spontaneous bacterial peritonitis in cirrhosis: Frequency and predictive factors. Hepatology 1988; 8: 27-31.
25. Sherman M. Screening for hepatocellular carcinoma. Baillière's Clinical Gastroenterology 1999; 13: 623-35.
26. Piai G, Cipolletta L, Claar M, Marone G, Bianco MA, Forte G, Iodice G, Mattera D, Minieri M, Roccop P, et al. Prophylactic sclerotherapy of high risk esophageal varices: Results of a multicentric prospective controlled trial. Hepatology 1988; 8: 1495-500.
27. Kobe E, Zipprich B, Schentke KU, Nilius R. Prophylactic endoscopic sclerotherapy of esophageal varices. A prospective randomized trial. Endoscopy 1990; 22: 245-8.
28. Sarin SK, Guptan RK, Jain AK, Sundaram KR. A randomized controlled trial of endoscopic variceal band ligation for primary prophylaxis of variceal bleeding. Eur J Gastroenterol Hepatol 1996; 8: 337-42.
29. Lo GH, Lai KH, Cheng JS, Lin CK, Hsu PI, Chiang HT. Prophylactic banding ligation of high-risk esophageal varices in patients with cirrhosis: a prospective, randomized trial. J Hepatol 1999; 31: 451-6.